Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 29.40
-0.10 (-0.34%)
Aug 28, 2026, 4:59 PM CET
Embla Medical Ratios and Metrics
Market cap in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12,521 | 13,888 | 15,199 | 11,537 | 14,096 | 17,859 | |
Market Cap Growth | -8.38% | -8.62% | 31.74% | -18.15% | -21.07% | -12.65% |
Enterprise Value | 15,404 | 16,833 | 18,292 | 14,270 | 17,043 | 20,367 |
Last Close Price | 29.40 | 32.50 | 35.60 | 27.45 | 33.55 | 42.30 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.52 | 26.20 | 30.90 | 29.30 | 47.64 | 42.69 |
Forward PE | 17.85 | 22.07 | 23.84 | 22.12 | 26.05 | 32.70 |
PS Ratio | 1.94 | 2.35 | 2.47 | 2.18 | 2.82 | 3.80 |
PB Ratio | 2.07 | 2.44 | 2.70 | 2.43 | 3.19 | 4.36 |
P/FCF Ratio | 15.19 | 19.75 | 23.70 | 26.29 | 45.80 | 32.69 |
P/OCF Ratio | 13.39 | 16.46 | 18.18 | 18.14 | 33.33 | 27.17 |
PEG Ratio | 1.09 | 1.03 | 2.02 | 0.58 | 1.18 | 5.74 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.39 | 2.85 | 2.97 | 2.69 | 3.41 | 4.34 |
EV/EBITDA Ratio | 12.23 | 17.63 | 18.55 | 19.54 | 27.37 | 25.99 |
EV/EBIT Ratio | 17.04 | 21.22 | 22.52 | 24.20 | 36.47 | 32.58 |
EV/FCF Ratio | 18.69 | 23.94 | 28.52 | 32.51 | 55.37 | 37.28 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.58 | 0.61 | 0.64 | 0.66 | 0.76 | 0.72 |
Debt / EBITDA Ratio | 2.84 | 3.02 | 3.08 | 3.58 | 4.35 | 3.17 |
Debt / FCF Ratio | 4.24 | 4.90 | 5.61 | 7.19 | 10.88 | 5.36 |
Net Debt / Equity Ratio | 0.47 | 0.49 | 0.53 | 0.56 | 0.64 | 0.58 |
Net Debt / EBITDA Ratio | 2.76 | 2.92 | 3.02 | 3.65 | 4.52 | 3.03 |
Net Debt / FCF Ratio | 3.46 | 3.97 | 4.65 | 6.07 | 9.14 | 4.34 |
Asset Turnover | 0.58 | 0.57 | 0.59 | 0.58 | 0.56 | 0.58 |
Inventory Turnover | 2.33 | 2.27 | 2.29 | 2.24 | 2.36 | 2.67 |
Quick Ratio | 0.67 | 0.83 | 1.03 | 1.05 | 0.82 | 1.02 |
Current Ratio | 1.25 | 1.48 | 1.90 | 1.92 | 1.47 | 1.71 |
Return on Equity (ROE) | 10.71% | 9.98% | 9.28% | 8.77% | 6.85% | 10.91% |
Return on Assets (ROA) | 4.93% | 4.77% | 4.82% | 4.03% | 3.26% | 4.86% |
Return on Invested Capital (ROIC) | 7.60% | 7.64% | 7.48% | 6.32% | 5.09% | 7.44% |
Return on Capital Employed (ROCE) | 10.00% | 8.80% | 8.50% | 7.40% | 6.20% | 9.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.91% | 3.82% | 3.24% | 3.41% | 2.10% | 2.34% |
FCF Yield | 6.58% | 5.06% | 4.22% | 3.80% | 2.18% | 3.06% |
Buyback Yield / Dilution | -0.99% | -0.08% | -1.51% | -0.60% | 1.17% | -0.02% |
Total Shareholder Return | -0.99% | -0.08% | -1.51% | -0.60% | 1.17% | -0.02% |